<p>Kaplan Meier curves represents OS according to A) MYC protein expression, B) FOXP1 protein expression, C) presence of MYC and BCL2 expression, D) <i>MYC</i> translocation, E) <i>BCL2</i> translocation, F) BCL2 protein expression.</p
Diffuse large B-cell lymphoma (DLBCL) is an aggressive non-Hodgkin lymphoma with marked biologic het...
MYC alterations influence the survival of patients with diffuse large B-cell lymphoma. Most studies ...
AIMS: Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease with various genetic alterati...
<p>Kaplan-Meier curve of overall survival (A) and event-free survival (B) in DLBCL patients accordin...
<p>(A) Patients bearing CXCR7+ tumors showed significantly higher OS than patients bearing CXCR7- tu...
<p>Patients bearing CXCR4+CXCR7- tumors showed the lowest OS compared with the other patient groups ...
<p>PFS (A and C) and lymphoma-associated OS (B and D) rates according to indicated genomic aberratio...
Introduction. C-MYC is one of the essential transcription factors that play a role in various cellul...
<p>Panels show: <b>A.</b> the influence of all alterations affecting the CHK2 coding sequence (cds; ...
<p>Kaplan-Meier curve depicting the statistically significant (p = 0.01, log rank test) difference i...
<p>Patients’ tumors were stained for (A, B) MYC, (C, D) BCL2, (E, F) BCL6, and (G, H) Ki67. The numb...
<p>Squares represent the HR of each study, and the area of each square was proportional to the weigh...
<p>Patients’ tumors were stained for (A, B) MYC, (C, D) BCL2, (E, F) BCL6, and (G, H) Ki67. The numb...
Diffuse large B-cell lymphoma (DLBCL) is an aggressive non-Hodgkin lymphoma with marked biologic het...
This journal issue is proceedings of ASH Conference 2012Open Access JournalOral Sessions - 622. Non-...
Diffuse large B-cell lymphoma (DLBCL) is an aggressive non-Hodgkin lymphoma with marked biologic het...
MYC alterations influence the survival of patients with diffuse large B-cell lymphoma. Most studies ...
AIMS: Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease with various genetic alterati...
<p>Kaplan-Meier curve of overall survival (A) and event-free survival (B) in DLBCL patients accordin...
<p>(A) Patients bearing CXCR7+ tumors showed significantly higher OS than patients bearing CXCR7- tu...
<p>Patients bearing CXCR4+CXCR7- tumors showed the lowest OS compared with the other patient groups ...
<p>PFS (A and C) and lymphoma-associated OS (B and D) rates according to indicated genomic aberratio...
Introduction. C-MYC is one of the essential transcription factors that play a role in various cellul...
<p>Panels show: <b>A.</b> the influence of all alterations affecting the CHK2 coding sequence (cds; ...
<p>Kaplan-Meier curve depicting the statistically significant (p = 0.01, log rank test) difference i...
<p>Patients’ tumors were stained for (A, B) MYC, (C, D) BCL2, (E, F) BCL6, and (G, H) Ki67. The numb...
<p>Squares represent the HR of each study, and the area of each square was proportional to the weigh...
<p>Patients’ tumors were stained for (A, B) MYC, (C, D) BCL2, (E, F) BCL6, and (G, H) Ki67. The numb...
Diffuse large B-cell lymphoma (DLBCL) is an aggressive non-Hodgkin lymphoma with marked biologic het...
This journal issue is proceedings of ASH Conference 2012Open Access JournalOral Sessions - 622. Non-...
Diffuse large B-cell lymphoma (DLBCL) is an aggressive non-Hodgkin lymphoma with marked biologic het...
MYC alterations influence the survival of patients with diffuse large B-cell lymphoma. Most studies ...
AIMS: Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease with various genetic alterati...